XML 128 R22.htm IDEA: XBRL DOCUMENT v3.20.1
Note 14 - Income Taxes
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
14.
INCOME TAXES
 
(Loss) income before income taxes consisted of the following:
 
(In thousands)
 
For the Years Ended December 31,
 
   
2019
   
2018
   
2017
 
Continuing operations
  $
(16,582
)
  $
(22,666
)
  $
(16,196
)
Discontinued operations
   
12,908
     
5,135
     
2,001
 
Loss before income taxes
  $
(3,674
)
  $
(17,531
)
  $
(14,195
)
 
Loss from continuing operations before taxes consisted of the following:               
 
(In thousands)
 
For the Years Ended December 31,
 
   
2019
   
2018
   
2017
 
U.S. operations
  $
(11,278
)
  $
(9,684
)
  $
(8,792
)
Foreign operations
   
(5,304
)
   
(12,982
)
   
(7,404
)
Loss before income taxes
  $
(16,582
)
  $
(22,666
)
  $
(16,196
)
 
The income tax (benefit) expense allocation for the years ended
December 31, 2019,
2018,
and
2017
consisted of the following:
 
(In thousands)
 
For the Years Ended December 31,
 
   
2019
   
2018
   
2017
 
Continuing operations
  $
(2,956
)
  $
(1,342
)
  $
(2,251
)
Discontinued operations
   
411
     
1,136
     
645
 
Total income tax (benefit)
  $
(2,545
)
  $
(206
)
  $
(1,606
)
 
The income tax (benefit) from continuing operations consisted of the following:
 
(In thousands)
 
For the Years Ended December 31,
 
   
2019
   
2018
   
2017
 
Current:
                       
Federal
  $
    $
    $
 
State and local
   
     
     
 
Foreign
   
     
     
 
Total current provision
   
     
     
 
Deferred:
                       
Federal
   
(2,368
)
   
(894
)
   
(1,370
)
State and local
   
(588
)
   
(142
)
   
(1
)
Foreign
   
     
(306
)
   
(880
)
Total deferred (benefit)
   
(2,956
)
   
(1,342
)
   
(2,251
)
Total income tax (benefit)
  $
(2,956
)
  $
(1,342
)
  $
(2,251
)
 
The following table provides a reconciliation of the federal statutory tax at
21%
to the recorded tax expense (benefit) from continuing operations for the years ended
December 31, 2019
and
2018,
respectively, and
34%
to the recorded tax expense (benefit) for the year ended
December 
31,
2017:
 
(In thousands)
 
For the Years Ended December 31,
 
   
2019
   
2018
   
2017
 
Computed federal income taxes at the statutory rate (benefit)
  $
(3,482
)
  $
(4,760
)
  $
(5,507
)
Permanent tax differences
   
(23
)
   
(122
)
   
(262
)
Foreign tax rates and tax credits differing from USA
   
435
     
747
     
1,021
 
Purchased goodwill and intangible impairments
   
     
828
     
1,072
 
Change in valuation allowance
   
114
     
1,965
     
1,425
 
Total income tax (benefit)
  $
(2,956
)
  $
(1,342
)
  $
(2,251
)
                         
Effective tax rate
   
17.83
%
   
5.92
%
   
13.90
%
 
The Company accounts for income taxes under the asset-liability method. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided when it is “more likely than
not”
that the benefits of existing deferred tax assets will
not
be realized in a future period. Significant components of the Company’s deferred tax assets and liabilities as of
December 
31,
2019
and
2018,
respectively, are as follows:
 
(In thousands)
 
As of December 31,
 
   
2019
   
2018
 
Deferred tax assets:
               
Net operating loss carryforwards
  $
12,130
    $
12,317
 
Inventory and accounts receivable reserves
   
306
     
234
 
Other
   
1,956
     
569
 
Valuation allowance
   
(12,447
)
   
(12,333
)
Deferred tax assets after valuation allowance
   
1,945
     
787
 
Deferred tax liabilities
               
Intangible assets
   
(476
)
   
(848
)
Property, plant and equipment
   
(1,469
)
   
61
 
Total deferred tax liabilities
   
(1,945
)
   
(787
)
Net deferred tax asset (liability)
  $
    $
 
 
The Company adopted the provisions of ASU
2015
-
17
in
2015.
ASU
2015
-
17
requires that all deferred tax assets and liabilities be classified as noncurrent on the balance sheet. The net deferred tax liability is recorded as of
December 31, 2019
and
December 31, 2018
as follows were
zero
for both year-end dates:
 
As of
December 
31,
2019
and
2018,
the Company recorded a valuation allowance of
$12.4
million and
$12.3
million, respectively. During the year ended
December 
31,
2019
and
2018,
the Company recorded an increase in valuation allowance of
$0.1
million and
$2.0
 million, respectively. As of
December 
31,
2019,
the Company has available federal, state and foreign net operating loss carry forwards of approximately
$37.2
million,
$32.3
million and
$15.5
million, respectively which have various expiration dates beginning in
2027
through
2038.
 
The Company files consolidated income tax returns for federal and many state jurisdictions in addition to separate subsidiary income tax returns in Canada, Japan and the United Kingdom. As of
December 31, 2019,
the Company is
not
under examination by any income tax jurisdiction. The Company is
no
longer subject to examination in the USA for years prior to
2016.
 
The Company accounts for income tax uncertainties using a threshold of "more-likely-than-
not"
in accordance with the provisions of ASC Topic
740,
Income Taxes ("ASC
740"
). As of
December 31, 2019,
the Company has reviewed all of its tax filings and positions taken on its returns and has
not
identified any material current or future effect on its consolidated results of operations, cash flows or financial position. As such, the Company has
not
recorded any tax, penalties or interest on tax uncertainties. It is Company policy to record any interest on tax uncertainties as a component of income tax expense.